Novartis Venture Funds

Category:

Corporate Venture

Description:

Novartis Venture Funds primarily focuses on the development of novel therapeutics and platforms. NVF looks for unmet need and clinical impact, novel proprietary science and understanding of mechanism, management and board experience and capital efficiency in the program. Novartis Venture Funds invests in North America, Europe, Israel and Asia/Pacific and manage over USD 1 billion in committed capital and more than 40 portfolio companies. NVF makes equity investments in life sciences companies across Biotechnology/Biopharma, Medical Devices and Diagnostics. NVF is stage agnostic and engages in seed investments as well as later-stage investments, typically leading or co-leading an investment and playing an active role on company boards.

Location:

Switzerland

Basel

Industries:

🏥 Health Care

🧬 Biotechnology

Stages:

Seed

Series A

Series B

Series C

Series D

Series E

Notes:

Sector Restriction